Advances in genomics and cancer biology will alter the design of human cancer studies.
Advertisement
The Scientist
Most Recent
Contributors
| April 1, 2013
Meet some of the people featured in the April 2013 issue of The Scientist.
A decade into the age of genomics, science is generating a flood of data that will help in the quest to eradicate the disease.
The regulatory body that licenses drugs for use in the European Union is devising a policy that will require the publication of some clinical trial data.
A Portuguese professor explores the poisons and potions of opera.
Does the preference of many scientists to only hear talks from successful institutions limit the reach of innovation?
The sculptures of Mara G. Haseltine's new exhibition tell a tale of beautiful oceans ravaged by pollution.
Artist Mara G. Haseltine unveils her latest exhibition of science-inspired sculpture, a melancholy ode to marine plankton set to the music of Puccini.
Tailoring ethical oversight to participant-led research
Two experts propose replacing Phase 3 trials with smaller, faster alternatives and post-market surveillance to invigorate the pharmaceutical industry.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
